Table 3.
Variable | No. of patients | 5-Year Survival (%) | Hazard Ratio (95% CI) | Log-Rank p value |
---|---|---|---|---|
All patients | 43 | 45 | ||
| ||||
Gender | 1.12 (0.5–2.6) | 0.76 | ||
Female | 18 | 41 | ||
Male | 25 | 44 | ||
| ||||
Age (years) | 2.19 (1.0–4.9) | 0.04 | ||
>55 | 21 | 30 | ||
≤55 | 22 | 59 | ||
| ||||
Tumor depth* | 4.53 (1.4–15.6) | 0.01 | ||
Visceral | 8 | 12 | ||
Deep | 24 | 46 | ||
Superficial | 11 | 68 | ||
| ||||
Tumor location** | 3.34 (0.97–13) | 0.054 | ||
Retroperitoneal-visceral | 8 | 13 | ||
Axial | 9 | 42 | ||
Lower Extremity | 19 | 54 | ||
Upper extremity | 7 | 66 | ||
| ||||
Size of primary tumor (cm)* | 5.85 (0.6–107) | 0.03 | ||
>10 | 14 | 29 | ||
5–10 | 19 | 44 | ||
<5 | 6 | 100 | ||
| ||||
Margin Status at Resection | 1.82 (0.6–4.7) | 0.22 | ||
R1 | 9 | 44 | ||
R0 | 25 | 56 | ||
| ||||
Metastatic at initial diagnosis | 5.0 (1.8–12) | 0.0003 | ||
Yes | 6 | 0 | ||
No | 37 | 53 | ||
| ||||
Recurrence status | 7.3 (2.6–26) | 0.0001 | ||
Recurrence (local and/or distant) | 20 | 20 | ||
No recurrence | 19 | 79 |
Hazard ratio comparing first and third categories.
Hazard ratio comparing first and fourth categories.